1. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells.
- Author
-
Lessard J and Sauvageau G
- Subjects
- Animals, Cell Division, Clone Cells cytology, Clone Cells metabolism, Gene Deletion, Genotype, Leukemia metabolism, Liver cytology, Liver embryology, Liver metabolism, Mice, Neoplasm Transplantation, Neoplastic Stem Cells metabolism, Nuclear Proteins genetics, Polycomb Repressive Complex 1, Proto-Oncogene Proteins genetics, Stem Cells metabolism, Leukemia pathology, Neoplastic Stem Cells pathology, Nuclear Proteins metabolism, Proto-Oncogene Proteins metabolism, Repressor Proteins, Stem Cells cytology
- Abstract
An emerging concept in the field of cancer biology is that a rare population of 'tumour stem cells' exists among the heterogeneous group of cells that constitute a tumour. This concept, best described with human leukaemia, indicates that stem cell function (whether normal or neoplastic) might be defined by a common set of critical genes. Here we show that the Polycomb group gene Bmi-1 has a key role in regulating the proliferative activity of normal stem and progenitor cells. Most importantly, we provide evidence that the proliferative potential of leukaemic stem and progenitor cells lacking Bmi-1 is compromised because they eventually undergo proliferation arrest and show signs of differentiation and apoptosis, leading to transplant failure of the leukaemia. Complementation studies showed that Bmi-1 completely rescues these proliferative defects. These studies therefore indicate that Bmi-1 has an essential role in regulating the proliferative activity of both normal and leukaemic stem cells.
- Published
- 2003
- Full Text
- View/download PDF